论文部分内容阅读
目的探讨妊娠期糖尿病(GDM)患者阴道试产母婴结局的影响因素。方法对该院收治的并且经过阴道试产的GDM患者193例以及同期185例正常妊娠患者(对照组)阴道试产的临床资料进行回顾性分析。结果 193例阴道试产的GDM患者,血糖稳定组148例,血糖不稳定组45例。对照组、血糖稳定组和血糖不稳定组孕妇在正常产、中转剖宫产、产钳助产、肩难产、产后出血、巨大儿、新生儿窒息、早产儿、低出生体质量儿、新生儿黄疸及新生儿低血糖差异有统计学意义(χ2=9.86、8.25、7.18、6.78、8.06、7.36、7.56、7.77、8.56、9.28、6.78,均P<0.05);但前两组(除外新生儿体质量)比较差异无统计学意义(均P>0.05),后两组比较差异有统计学意义(均P<0.05)。结论 GDM患者阴道试产是安全的,血糖控制平稳的其分娩结局与正常孕妇一样,应重视对GDM患者血糖的控制,把握阴道分娩的条件。
Objective To investigate the influencing factors of vaginal trial maternal and infant outcome in patients with gestational diabetes mellitus (GDM). Methods A retrospective analysis of 193 cases of GDM patients admitted to our hospital and vaginal trial and the vaginal trial of 185 normal pregnant women (control group) during the same period were retrospectively analyzed. Results 193 cases of vaginal trial of GDM patients, stable blood sugar 148 cases, 45 cases of unstable blood glucose group. The control group, stable blood glucose group and unstable blood glucose group were divided into three groups: normal birth, cesarean section, forceps midwifery, shoulder dystocia, postpartum hemorrhage, macrosomia, neonatal asphyxia, premature infant, low birth weight children, neonatal jaundice And neonatal hypoglycemia difference was statistically significant (χ2 = 9.86,8.25,7.18,6.78,8.06,7.36,7.56,7.77,8.56,9.28,6.78, all P <0.05); but the first two groups (except for neonates There was no significant difference between the two groups (P> 0.05). The difference between the two groups was statistically significant (P <0.05). Conclusions The vaginal trial of GDM patients is safe, and the stable blood glucose control of their delivery outcomes and normal pregnant women should pay attention to the control of blood glucose in GDM patients to grasp the conditions of vaginal delivery.